Fluence offers training and certificate programs in psychedelic-assisted therapy and integration.
Founded in 2019 and based in New York, Fluence provides courses and certificates for clinicians and other healthcare practitioners in psychedelic integration and assisted therapy. Its programs include Psychedelic Integration Therapy and Ketamine-Assisted Psychotherapy training, along with materials developed with drug developers for clinical trials. In February 2022, it raised USD 1.4 million in seed funding from Baroda Ventures, LearnStart, Evolve Ventures, Iter Investments, and individual investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in